GENOSS Coronary Stent Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.
Also called NCT05444452
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 850 participants
- Sponsor
- Registry
-
NCT05444452
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT05444452. Randomized; no masking; primary purpose treatment. Start 2022-04-24 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GENOSS Coronary Stent Clinical Trial
- Condition
- Ischemic Heart Disease
- Intervention (Device)
- Implanatation of Genoss DES sirolimus-eluting coronary system
- Intervention (Device)
- Implanatation of Xience DES everolimus-eluting coronary system
- Lead sponsor
- Samsung Medical Center
- Collaborator
- Genoss Company Limited, Suwon, Korea
Record details
- Record id
cardio:ct-nct05444452- Content hash
8ca7553167fe07e0acf241e43e324ae64a48f9e30673466f963e5364b10ca759